HOME >> MEDICINE >> NEWS
Cancer Patients Nationwide Can More Easily Navigate Health Care System

Company to Provide Funding and Support for 50 New American Cancer Society Patient Navigator Program Sites Throughout the U.S. Over the Next Five Years

Atlanta, GA /Wilmington, DE. February 14, 2007 AstraZeneca and the American Cancer Society today announced a strategic collaboration to significantly extend the reach of the Societys innovative Patient Navigator Program an initiative to assist individual cancer patients in negotiating the health care system. With major support from AstraZeneca, the American Cancer Society will accelerate development of at least 50 new Patient Navigator Program sites over the next five years in communities throughout the United States. The first three sites to launch are Seattle Cancer Care Alliance in Seattle, Washington; Helen F. Graham Cancer Center at Christiana Care in Wilmington, Delaware; and, John H. Stroger Jr. Hospital of Cook County in Chicago, Illinois. The American Cancer Society Patient Navigator Program provides individualized personal guidance for cancer patients, survivors, and caregivers to help them navigate the cancer experience. The Societys initiative places an emphasis on assisting the medically underserved. As part of its ongoing organizational commitment to patient health, AstraZeneca has pledged USD$10 million to help fund the Societys Patient Navigator Program operations, as well the time of its local employees and other resources to support the program.

A cancer diagnosis can be the most overwhelming experience a person may ever face, and we know that diagnosis is just the beginning of a challenging journey to successfully fight this disease, said Richard C. Wender, M.D., national volunteer president of the American Cancer Society. While there are many uncertainties associated with cancer, the Patient Navigator Program can relieve some of these anxieties by providing personalized support and education for the needs of each patient and their families.

The American Cance
'"/>

Contact: Kirsten Evraire
Kirsten.Evraire@astrazeneca.com
215-219-0368
Edelman Public Relations
14-Feb-2007


Page: 1 2 3

Related medicine news :

1. American Cancer Society to hold third annual Virtual Relay For Life in Second Life
2. Cancer research summaries
3. Cancer on the agenda of the Portuguese EU Council Presidency
4. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research
5. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
6. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
7. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
8. Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer
9. Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
10. Margaret Foti receives AACR Award for Leadership and Extraordinary Achievements in Cancer Research
11. Cancer-fighting foods, supplements explored in day-long symposium, March 25

Post Your Comments:
(Date:5/23/2013)... Jim Fitzpatrick just did it again. The ... outside-of-the-box approach to reaching the retail automotive industry. With ... to the retail automotive industry, blending the immediacy of ... format. , CBTNews.com is an innovative website covering ... and Russell Brown host the show with videos, news ...
(Date:5/23/2013)... Coral Springs, FL (PRWEB) May 23, 2013 ... segment about redefining retirement. Many Americans are facing a dim ... stated the Late Boomers -- those born after 1955 -- ... credit card debt. But all hope for The Golden Years ... about how to reduce debt and keep earning after reaching ...
(Date:5/23/2013)... can cause rapidly progressing, life threatening meningitis and meningococcal ... have not known how it attaches to the human ... attaches to the airway to colonise", People can be ... while some people progress to invasive disease. To ... how the bacterium colonises the airway. Now that the ...
(Date:5/23/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) -- ... detecting lung cancer now have more information to help with ... finds that low-dose CT scans pick up significantly more lung ... history of smoking are at high risk for lung cancer, ... doctors have to consider the potential harm of radiation exposure ...
(Date:5/23/2013)... Los Angeles,Ca (PRWEB) May 23, 2013 ... with removing every sign associated with Rosacea. This condition ... skin and can affect a person’s self-image. Manufacturers have ... work to help constrict blood vessels near the surface ... and flushing. The new formula is available with special ...
Breaking Medicine News(10 mins):Health News:Fitzpatrick Advertising Founder Brings Auto Industry into Focus with CBT News 2Health News:Viewpoints with Terry Bradshaw Presents a Series on Redefining Retirement 2Health News:New discovery in fight against deadly meningococcal disease 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 3Health News:Revitol Rosacea Now Comes with Anti-Inflammatory Ingredients to Remove Redness and Flushing 2
(Date:5/23/2013)... 2013  Omeros Corporation (NASDAQ: OMER ... Application (IND) to evaluate OMS824 in Huntington,s disease ... Drug Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 ... brain linked to a wide range of diseases ... OMS824 has shown promising results in animal models ...
(Date:5/23/2013)... -- Echo Pharma Acquisition Limited ("Royalty Pharma") announced today that ... from 90 percent to 50 percent of Maximum Elan ... the terms of the Revised Offer Document issued today, ... the terms of the Increased Offer, Royalty Pharma is ... for $12.50 per share in cash. The Increased Offer ...
(Date:5/23/2013)... Engeland, May 23, 2013 Nederland ... met lagere urinewegsymptomen geassocieerd met BPH Astellas ... dochteronderneming van Astellas Pharma Inc, gebaseerd in ... kondigde vandaag aan dat het Nederlandse College ter Beoordeling ... in Nederland. De handelsvergunning verleend voor VESOMNI ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4
Cached News: